The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.

Lung cancer is the leading cause of cancer-related death in humans and the multidrug resistance (MDR) is the major obstacle to successful chemotherapy of lung cancer. In this study, a d-α-tocopheryl polyethylene glycol 1000 succinate-triphenylphosphine conjugate (TPGS1000-TPP) was synthesized as the mitochondrial targeting molecule, and was incorporated onto the surface of paclitaxel liposomes to treat the drug-resistant lung cancer. Evaluations were performed on the human lung cancer A549 cells, the drug-resistant lung cancer A549/cDDP cells, and the drug-resistant lung cancer A549/cDDP cells xenografted nude mice. The yield of TPGS1000-TPP conjugate synthesized was about 50% and the particle size of targeting paclitaxel liposomes developed was approximately 80 nm. In comparison with taxol and regular paclitaxel liposomes, the targeting paclitaxel liposomes exhibited the strongest anticancer efficacy in vitro and in the drug-resistant A549/cDDP xenografted tumor model. The targeting paclitaxel liposomes could significantly enhance the cellular uptake, be selectively accumulated into the mitochondria, and cause the release of cytochrome C. This targeting delivery of drug initiated a cascade of caspase 9 and 3 reactions, activated the pro-apoptotic Bax and Bid proteins and suppressed the anti-apoptotic Bcl-2 protein, thereby enhancing the apoptosis by acting on the mitochondrial signaling pathways. In conclusion, the targeting paclitaxel liposomes have the potential to treat drug-resistant lung cancer.

[1]  V. Torchilin,et al.  Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  D. Braguer,et al.  Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'. , 2000, Cancer research.

[3]  K. Griffioen,et al.  Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. , 2004, Neurotoxicology.

[4]  So H. Kim,et al.  Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol , 2005 .

[5]  M. Varma,et al.  Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Dmitry Nevozhay,et al.  [Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases]. , 2007, Postepy higieny i medycyny doswiadczalnej.

[7]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[8]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[9]  Jie Pan,et al.  Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.

[10]  M. Murphy,et al.  Targeting lipophilic cations to mitochondria. , 2008, Biochimica et biophysica acta.

[11]  A. Harris,et al.  Mechanisms of multidrug resistance in cancer treatment. , 1992, Acta oncologica.

[12]  J. Kopeček,et al.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting. , 2008, Molecular pharmaceutics.

[13]  Yang Liu,et al.  A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Chee Wee Gan,et al.  Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. , 2010, Biomaterials.

[15]  I. Herr,et al.  Cellular stress response and apoptosis in cancer therapy. , 2001, Blood.

[16]  Yan Zhang,et al.  All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[17]  R. Tiwari,et al.  Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.

[18]  W. J. Duncanson,et al.  ApJ, in press , 1999 .

[19]  J. Neuzil,et al.  Mitochondrially targeted anti-cancer agents. , 2010, Mitochondrion.

[20]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[21]  F. Gallyas,et al.  Direct effect of Taxol on free radical formation and mitochondrial permeability transition. , 2001, Free radical biology & medicine.

[22]  N. Neamati,et al.  Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity , 2010, PloS one.

[23]  D. Aggarwal,et al.  Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.

[24]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[25]  A. García-Sáez.  The secrets of the Bcl-2 family , 2012, Cell Death and Differentiation.

[26]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[27]  R. Reddel,et al.  Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo. , 2002, Cancer research.

[28]  Xiangliang Yang,et al.  Copolymer technology for advanced nanomedicine. , 2011, Nanomedicine.

[29]  H. Harashima,et al.  Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. , 2008, Advanced drug delivery reviews.

[30]  Si-Shen Feng,et al.  Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. , 2011, International journal of pharmaceutics.

[31]  H. Kovacic,et al.  Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells , 2002, FEBS letters.

[32]  D. Green,et al.  The machinery of programmed cell death. , 2001, Pharmacology & therapeutics.

[33]  P. Lai,et al.  Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells. , 2010, Biomacromolecules.

[34]  M. Murphy,et al.  Selective targeting of bioactive compounds to mitochondria. , 1997, Trends in biotechnology.

[35]  Yan Zhang,et al.  The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. , 2011, Biomaterials.

[36]  N. Das,et al.  Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges , 2012, ISRN pharmacology.

[37]  P. Ma,et al.  Cancer genes in lung cancer: racial disparities: are there any? , 2012, Genes & cancer.

[38]  J. Neuzil,et al.  Anticancer drugs targeting the mitochondrial electron transport chain. , 2011, Antioxidants & redox signaling.

[39]  V. Torchilin,et al.  Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. , 2012, Biomaterials.

[40]  Carol L. Williams,et al.  Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells , 2011, Cancer biology & therapy.

[41]  Yan Zhang,et al.  The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. , 2011, Biomaterials.

[42]  Claus-Michael Lehr,et al.  Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. , 2010, Molecular pharmaceutics.

[43]  S. Mulero-Navarro,et al.  Resveratrol‐induced apoptosis in MCF‐7 human breast cancer cells involves a caspase‐independent mechanism with downregulation of Bcl‐2 and NF‐κB , 2005, International journal of cancer.

[44]  J. Martinou,et al.  Cytochrome c release from mitochondria: all or nothing , 2000, Nature Cell Biology.

[45]  So‐Hee Kim,et al.  Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. , 2005, Journal of Controlled Release.